Disease | pneumocystosis |
Comorbidity | C0003873|rheumatoid arthritis |
Sentences | 9 |
PubMedID- 26396551 | pneumocystis jirovecii pneumonia in rheumatoid arthritis patients: risks and prophylaxis recommendations. |
PubMedID- 24495443 | Prophylaxis for pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study. |
PubMedID- 21384675 | [clinical study of pneumocystis pneumonia in patients with rheumatoid arthritis]. |
PubMedID- 21881284 | Intestinal perforation due to concomitant cytomegalovirus infection during treatment for pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis. |
PubMedID- 23212592 | Clinical characteristics and risk factors for pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients. |
PubMedID- 20824796 | Trends in hospitalizations for pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the us: 1996-2007. |
PubMedID- 24881737 | Deterioration of the immune response induced by sulfamethoxazole-trimethoprim in a rheumatoid arthritis patient with pneumocystis jirovecii pneumonia. |
PubMedID- 21971942 | Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (ra) and non-ra rheumatic diseases. |
PubMedID- 25313341 | pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with abatacept. |
Page: 1